Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.21 | -$0.15 | -$0.18 |
| Q2 2026 | 2 | -$0.23 | -$0.17 | -$0.20 |
| Q3 2026 | 2 | -$0.22 | -$0.16 | -$0.19 |
| Q4 2026 | 1 | -$0.22 | -$0.16 | -$0.19 |
| Q1 2027 | 1 | -$0.09 | -$0.07 | -$0.08 |
| Q2 2027 | 1 | -$0.11 | -$0.07 | -$0.09 |
| Q3 2027 | 1 | -$0.14 | -$0.10 | -$0.12 |
| Q4 2027 | 1 | -$0.22 | -$0.16 | -$0.19 |
InspireMD Inc last posted its earnings results on Monday, May 4th, 2026. The company reported $-0.16 earnings per share for the quarter, topping analysts' consensus estimates of $-0.19 by $0.03. The company had revenue of 3.40 M for the quarter and had revenue of 8.98 M for the year. InspireMD Inc has generated $-1 earnings per share over the last year ($-0.76 diluted earnings per share) and currently has a price-to-earnings ratio of -1.26. InspireMD Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | N/A | $0.00 | N/A | $2.70 M | $3.40 M |
| 03/18/2026 | Q4 2025 | -$0.22 | -$0.14 | 0.08 | $2.63 M | $3.15 M |
| 11/10/2025 | Q3 2025 | N/A | -$0.17 | N/A | $1.76 M | $2.52 M |
| 08/04/2025 | Q2 2025 | -$0.24 | -$0.26 | -0.02 | $1.52 M | $1.78 M |
| 05/08/2025 | Q1 2025 | N/A | -$0.22 | N/A | $1.45 M | $1.53 M |
| 03/12/2025 | Q4 2024 | -$0.20 | -$0.19 | 0.01 | $1.82 M | $1.95 M |
| 11/12/2024 | Q3 2024 | -$0.20 | -$0.16 | 0.04 | $1.74 M | $1.81 M |
| 08/05/2024 | Q2 2024 | N/A | -$0.22 | N/A | $1.74 M | $1.74 M |
| 05/13/2024 | Q1 2024 | N/A | -$0.21 | N/A | $2.00 M | $1.51 M |
| 03/05/2024 | Q4 2023 | N/A | -$0.25 | N/A | N/A | $1.76 M |
| 11/06/2023 | Q3 2023 | -$0.17 | -$0.15 | 0.02 | N/A | $1.56 M |
| 08/07/2023 | Q2 2023 | N/A | -$0.24 | N/A | N/A | $1.65 M |
| 05/15/2023 | Q1 2023 | -$0.68 | -$0.53 | 0.15 | N/A | $1.24 M |
| 03/30/2023 | Q4 2022 | $0.84 | -$0.60 | -1.44 | N/A | $1.03 M |
| 11/07/2022 | Q3 2022 | N/A | -$0.58 | N/A | N/A | $1.43 M |
| 08/08/2022 | Q2 2022 | N/A | -$0.59 | N/A | N/A | $1.53 M |
| 05/09/2022 | Q1 2022 | N/A | -$0.57 | N/A | N/A | $1.18 M |
| 03/07/2022 | Q4 2021 | N/A | -$0.53 | N/A | N/A | $1.38 M |
| 11/08/2021 | Q3 2021 | N/A | -$0.53 | N/A | N/A | $1.07 M |
| 08/09/2021 | Q2 2021 | N/A | -$0.46 | N/A | N/A | $1.04 M |
In the previous quarter, InspireMD Inc (:NSPR) reported $-0.16 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.19 by $0.03.
The conference call for InspireMD Inc's latest earnings report can be listened to online.
The conference call transcript for InspireMD Inc's latest earnings report can be read online.
InspireMD Inc (:NSPR) has a recorded annual revenue of $8.98 M.
InspireMD Inc (:NSPR) has a recorded net income of $-48,786,000.InspireMD Inc has generated $-0.76 earnings per share over the last four quarters.
InspireMD Inc (:NSPR) has a price-to-earnings ratio of -1.26 and price/earnings-to-growth ratio is -0.05.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED